AU StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

NYRADA INC-CDI

0.190

0.000

Volume:839.40K

Turnover:161.88K

Market Cap:40.07M

PE:-8.70

High:0.195

Open:0.190

Low:0.190

Close:0.190

Loading ...

Overview Company News Filings

Company Profile

Company Name:

NYRADA INC-CDI

Exchange:

ASX

Establishment Date:

2017

Employees:

- -

Office Location:

Sydney Place,Level 22/23, Salesforce Tower,180 George Street,Sydney,New South Wales,Australia

Website:

http://www.nyrada.com

Zip Code:

2000

Phone:

Fax:

- -

Introduction:

Nyrada Inc., a pre-clinical stage drug development company, engages in the development of small molecule drugs for cardiovascular, neurodegenerative, and chronic inflammatory diseases. Its products in drug development stage include PCSK9 inhibitor for the treatment of high blood LDL-cholesterol levels in patients poorly responsive to or unable to take statin drugs; a neuroprotectant drug to reduce the impact of long-term disability in patients with ischaemic stroke and traumatic brain injury; a drug to treat pain associated with peripheral nerve damage; and a drug to treat autoimmune diseases, such as psoriasis. The company was founded in 2017 and is based in Gordon, Australia.

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/NYR.AU/company"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"NYR.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NYR.AU\",,,,,undefined,":{"symbol":"NYR.AU","market":"AU","secType":"STK","nameCN":"NYRADA INC-CDI","latestPrice":0.19,"timestamp":1749190320000,"preClose":0.19,"halted":0,"volume":839396,"delay":0,"nameEN":"NYRADA INC-CDI","floatShares":129248884,"shares":210917037,"eps":-0.021836,"marketStatus":"Not Yet Opened","change":0,"latestTime":"06-06 16:12:00 AEST","open":0.19,"high":0.195,"low":0.19,"amount":161883,"amplitude":0.026316,"askPrice":0.19,"askSize":92445,"bidPrice":0.185,"bidSize":210675,"shortable":3,"etf":0,"ttmEps":-0.021836,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1749513600000},"marketStatusCode":0,"adr":0,"exchange":"ASX","adjPreClose":0.19,"openAndCloseTimeList":[[1749168000000,1749189600000]],"volumeRatio":0.5511266635116628,"lotSize":1,"tradeCurrency":"AUD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NYR.AU\",,,,,undefined,":{"symbol":"NYR.AU","floatShares":129248884,"roa":"-45.16%","roe":"-76.35%","lyrEps":-0.008535,"volumeRatio":0.5511266635116628,"shares":210917037,"dividePrice":0,"high":0.195,"amplitude":0.026316,"preClose":0.19,"low":0.19,"week52Low":0.032,"pbRate":"6.84","psRate":"24.30","week52High":0.195,"institutionHeld":0,"latestPrice":0.19,"committee":0.390044,"eps":-0.021836,"divideRate":0,"volume":839396,"delay":0,"ttmEps":-0.021836,"open":0.19,"prevYearClose":0.094,"prevWeekClose":0.19,"prevMonthClose":0.165,"prevQuarterClose":0.107,"fiveDayClose":0.165,"twentyDayClose":0.105,"sixtyDayClose":0.105},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{"companyId":545429788,"yearFounded":2017,"address":"Sydney Place,Level 22/23, Salesforce Tower,180 George Street,Sydney,New South Wales,Australia","zipCode":"2000","officePhone":"61 2 9498 3390"},"stockCompanyDetail":{"websiteUrl":"http://www.nyrada.com","stockEarnings":[{"period":"1week","weight":0.1515},{"period":"1month","weight":0.7273},{"period":"3month","weight":0.6522},{"period":"6month","weight":0.7273},{"period":"1year","weight":1.6389},{"period":"ytd","weight":1.0213}],"compareEarnings":[{"period":"1week","weight":0.0014},{"period":"1month","weight":0.0414},{"period":"3month","weight":0.0546},{"period":"6month","weight":0.1356},{"period":"1year","weight":0.1958},{"period":"ytd","weight":0.1466}],"compareStock":{"symbol":"F100.AU","name":"BETASHARES FTSE 100 ETF"},"description":"Nyrada Inc., a pre-clinical stage drug development company, engages in the development of small molecule drugs for cardiovascular, neurodegenerative, and chronic inflammatory diseases. Its products in drug development stage include PCSK9 inhibitor for the treatment of high blood LDL-cholesterol levels in patients poorly responsive to or unable to take statin drugs; a neuroprotectant drug to reduce the impact of long-term disability in patients with ischaemic stroke and traumatic brain injury; a drug to treat pain associated with peripheral nerve damage; and a drug to treat autoimmune diseases, such as psoriasis. The company was founded in 2017 and is based in Gordon, Australia.","yearOnYearQuotes":[{"month":1,"riseRate":0.333333,"avgChangeRate":0.526713},{"month":2,"riseRate":0.333333,"avgChangeRate":-0.028308},{"month":3,"riseRate":0.333333,"avgChangeRate":0.007251},{"month":4,"riseRate":0.166667,"avgChangeRate":0.000203},{"month":5,"riseRate":0.5,"avgChangeRate":-0.102485},{"month":6,"riseRate":0.6,"avgChangeRate":0.147347},{"month":7,"riseRate":0.4,"avgChangeRate":-0.04515},{"month":8,"riseRate":0.2,"avgChangeRate":-0.075789},{"month":9,"riseRate":0.6,"avgChangeRate":0.186859},{"month":10,"riseRate":0.2,"avgChangeRate":-0.063966},{"month":11,"riseRate":0.8,"avgChangeRate":0.072515},{"month":12,"riseRate":0.4,"avgChangeRate":0.05601}],"exchange":"ASX","name":"NYRADA INC-CDI","nameEN":"NYRADA INC-CDI"}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"NYR.AU\",market:\"AU\",,,undefined,":null,"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/NYR.AU\",params:#limit:5,,,undefined,":[{"date":"2023-07-28","symbol":"NYR.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1690502400000,"name":null,"time":"","dateTimestamp":1690466400000,"actualEps":null},{"date":"2023-04-29","symbol":"NYR.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1682726400000,"name":null,"time":"","dateTimestamp":1682690400000,"actualEps":null},{"market":"AU","date":"2022-08-29","symbol":"NYR.AU","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1661695200000,"reportTimeType":"","actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"NYR.AU\",market:\"AU\",,,undefined,":[]}}